Organisation paid for research Program year 2025 Source: CMS Open Payments

Activmed Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$7,437

7 payments

Through program year 2025, Activmed Clinical Research is reported as receiving $7,437 in research payments, across 7 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $120 4
2024 Research $7,317 3

Breakdown

Who paid Research payments · program years 2024–2025
  1. Pfizer Inc. $4,266 2 payments
  2. Boehringer Ingelheim International GmbH $3,171 5 payments
Studies the money was for Research payments · program years 2024–2025
  1. A Phase 12 Randomized Observerblinded Study to Evaluate the Safety Tolerability and Immunogenicity of Combined Vaccine Candidates Against Influenza and Covid19 in Healthy Individuals $4,266 2 payments
  2. Phase II dose finding trial in monotherapy for MDD $3,171 5 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record